106 related articles for article (PubMed ID: 10892862)
21. Detecting progressive visual field loss.
Henson DB; Darling MN
Ophthalmic Physiol Opt; 1995 Sep; 15(5):387-90. PubMed ID: 8524561
[TBL] [Abstract][Full Text] [Related]
22. Natural history of open-angle glaucoma.
Heijl A; Bengtsson B; Hyman L; Leske MC;
Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
[TBL] [Abstract][Full Text] [Related]
23. Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes.
Turpin A; McKendrick AM; Johnson CA; Vingrys AJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):709-15. PubMed ID: 11867588
[TBL] [Abstract][Full Text] [Related]
24. Appearance of the pattern deviation map as a function of change in area of localized field loss.
Asman P; Wild JM; Heijl A
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3099-106. PubMed ID: 15326126
[TBL] [Abstract][Full Text] [Related]
25. Long-term survival of central visual field in end-stage glaucoma.
Much JW; Liu C; Piltz-Seymour JR
Ophthalmology; 2008 Jul; 115(7):1162-6. PubMed ID: 18067965
[TBL] [Abstract][Full Text] [Related]
26. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
Medeiros FA; Sample PA; Weinreb RN
Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, II: structure/function regression analysis in glaucoma.
Leung CK; Chong KK; Chan WM; Yiu CK; Tso MY; Woo J; Tsang MK; Tse KK; Yung WH
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3702-11. PubMed ID: 16186352
[TBL] [Abstract][Full Text] [Related]
28. Pointwise linear progression criteria and the detection of visual field change in a glaucoma trial.
Wilkins MR; Fitzke FW; Khaw PT
Eye (Lond); 2006 Jan; 20(1):98-106. PubMed ID: 15650759
[TBL] [Abstract][Full Text] [Related]
29. Comparison of mean deviation with AGIS and CIGTS scores in association with structural parameters in glaucomatous eyes.
Naka M; Kanamori A; Tatsumi Y; Fujioka M; Nagai-Kusuhara A; Nakamura M; Negi A
J Glaucoma; 2009; 18(5):379-84. PubMed ID: 19525728
[TBL] [Abstract][Full Text] [Related]
30. Diagnosing glaucoma progression: current practice and promising technologies.
Giangiacomo A; Garway-Heath D; Caprioli J
Curr Opin Ophthalmol; 2006 Apr; 17(2):153-62. PubMed ID: 16552250
[TBL] [Abstract][Full Text] [Related]
31. Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma.
Clement CI; Goldberg I; Healey PR; Graham S
Br J Ophthalmol; 2009 May; 93(5):582-8. PubMed ID: 18669543
[TBL] [Abstract][Full Text] [Related]
32. Detection of visual field progression in glaucoma.
Kovalska M; Grieshaber MC; Schötzau A; Katamay R; Hauenstein D; Flammer J; Orgül S
Klin Monbl Augenheilkd; 2008 May; 225(5):342-5. PubMed ID: 18454368
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma: a comparison between different test programs.
Bengtsson B; Heijl A
Ophthalmology; 2006 Jul; 113(7):1092-7. PubMed ID: 16815399
[TBL] [Abstract][Full Text] [Related]
34. Mapping of glaucomatous visual field defects by multifocal VEPs.
Hasegawa S; Abe H
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3341-8. PubMed ID: 11726643
[TBL] [Abstract][Full Text] [Related]
35. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
Bozkurt B; Yilmaz PT; Irkec M
J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
[TBL] [Abstract][Full Text] [Related]
36. Nerve fiber layer thickness in glaucoma patients with asymmetric hemifield visual field loss.
Badlani V; Shahidi M; Shakoor A; Edward DP; Zelkha R; Wilensky J
J Glaucoma; 2006 Aug; 15(4):275-80. PubMed ID: 16865002
[TBL] [Abstract][Full Text] [Related]
37. The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes.
Fogagnolo P; McNaught A; Centofanti M; Rossetti L; Orzalesi N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4557-63. PubMed ID: 17898278
[TBL] [Abstract][Full Text] [Related]
38. Structure versus function in glaucoma: an application of a linear model.
Hood DC; Anderson SC; Wall M; Kardon RH
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3662-8. PubMed ID: 17652736
[TBL] [Abstract][Full Text] [Related]
39. SITA standard in optic neuropathies and hemianopias: a comparison with full threshold testing.
Wall M; Punke SG; Stickney TL; Brito CF; Withrow KR; Kardon RH
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):528-37. PubMed ID: 11157893
[TBL] [Abstract][Full Text] [Related]
40. A strategy for averaged estimates of visual field threshold: spark.
de la Rosa MG; Gonzalez-Hernandez M
J Glaucoma; 2013; 22(4):284-9. PubMed ID: 23059476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
